MicroRNAs targeting TGF‐β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function
European Journal of Immunology · 2024
DOI: 10.1002/eji.202350548 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Christina N Rau und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Infection and Immunity, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Autoimmunity, Central Nervous System, Encephalomyelitis, Autoimmune, Experimental, MicroRNAs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, National Institute of Allergy and Infectious Diseases, National Multiple Sclerosis Society.
Abstract (Originalsprache)
Transforming growth factor beta (TGF‐β) signaling is essential for a balanced immune response by mediating the development and function of regulatory T cells (Tregs) and suppressing autoreactive T cells. Disruption of this balance can result in autoimmune diseases, including multiple sclerosis (MS). MicroRNAs (miRNAs) targeting TGF‐β signaling have been shown to be upregulated in naïve CD4 T cells in MS patients, resulting in a limited in vitro generation of human Tregs. Utilizing the murine model experimental autoimmune encephalomyelitis, we show that perinatal administration of miRNAs, which target the TGF‐β signaling pathway, enhanced susceptibility to central nervous system (CNS) autoimmunity. Neonatal mice administered with these miRNAs further exhibited reduced Treg frequencies with a loss in T cell receptor repertoire diversity following the induction of experimental autoimmune encephalomyelitis in adulthood. Exacerbated CNS autoimmunity as a result of miRNA overexpression in CD4 T cells was accompanied by enhanced Th1 and Th17 cell frequencies. These findings demonstrate that increased levels of TGF‐β‐associated miRNAs impede the development of a diverse Treg population, leading to enhanced effector cell activity, and contributing to an increased susceptibility to CNS autoimmunity. Thus, TGF‐β‐targeting miRNAs could be a risk factor for MS, and recovering optimal TGF‐β signaling may restore immune homeostasis in MS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbial Infection and Immunity, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.
- Biomedical Sciences Graduate Program, The Ohio State University, Columbus, Ohio, USA.
- Molecular, Cellular, and Developmental Biology Graduate Program, The Ohio State University, Columbus, Ohio, USA.
- Neuroscience Graduate Program, The Ohio State University, Columbus, Ohio, USA.
- Department of Neuroscience, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.
ORCID-Profile: Christina N Rau, Joshua L Deffenbaugh
Förderung
- NINDS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Multiple Sclerosis Society
- NIAID NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Rau, C. N., Severin, M. E., Lee, P. W., Deffenbaugh, J. L., Liu, Y., Murphy, S. P., Petersen-Cherubini, C. L., & Lovett-Racke, A. E. (2024). MicroRNAs targeting TGF‐β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function. European Journal of Immunology. https://doi.org/10.1002/eji.202350548
Vancouver
Rau CN, Severin ME, Lee PW, Deffenbaugh JL, Liu Y, Murphy SP, et al. MicroRNAs targeting TGF‐β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function. European Journal of Immunology. 2024. doi:10.1002/eji.202350548
BibTeX
@article{Rau2024,
author = {Rau, Christina N and Severin, Mary E and Lee, Priscilla W and Deffenbaugh, Joshua L and Liu, Yue and Murphy, Shawn P and Petersen-Cherubini, Cora L and Lovett-Racke, Amy E},
title = {MicroRNAs targeting TGF‐β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202350548}
}
EUVIMED